New research published in the bioRxiv* preprint server suggests a small cationic peptide known as crotamine may inhibit the replication and transcription of severe acute respiratory syndrome coronavirus...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. The virus rapidly spread worldwide, causing millions of morbidity and mortality cases, known as...

Lupus can cause genetic changes that support type I interferon (IFN) pathway activation. But the reason behind people continue to have a high frequency of lupus-associated risk alleles in the immune...

In the face of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants such as Delta, reasonable concerns have been raised over how COVID-19 vaccines are affected. But new research...

The coronavirus disease 2019 (COVID-19) pandemic has been a heavy blow to the world's health and wealth but is generally thought to have spared children. It is necessary to take a fresh look at...

Even with the rapid production and distribution of safe and effective coronavirus disease 2019 (COVID-19) vaccines, their availability in low-resource settings is an issue due to production, affordability,...

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a ribonucleic acid (RNA) virus that causes the coronavirus disease 2019 (COVID-19). RNA viruses are prone to high rates of mutation....

The United Kingdom began the widespread distribution of coronavirus disease 2019 (COVID-19) vaccines in early December 2020. By September 27, 2021, 89.6% of the adult population in the U.K. had received...

The rapid spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in the coronavirus disease 2019 (COVID-19) pandemic. To contain this pandemic, scientists have developed...

There was a difference in disease burden observed during the initial waves of the COVID-19 pandemic due to different infection rates influenced by factors including the type of occupation, ability to...